Conversational AI to drive the Genetic Toxicology Testing Market at a CAGR of 13%

The global genetic toxicology testing market garnered a market value of US$ 1.34 Billion in 2022 and is expected to accumulate a market value of US$ 4.56 Billion by registering a CAGR of 13% in the forecast period 2022-2032. Growth of the genetic toxicology testing market can be attributed to increasing drug development and discovery, along with the rising use of pharmacogenomics. The market for genetic toxicology testing registered a CAGR of 9% in the historical period 2016-2021

Companies
Thermo Fisher Scientific, Inc.
Charles River Laboratories International
Laboratory Corp of America Holdings
Eurofins Scientific
Jubilant Life Sciences Limited
Syngene International Limited
Gentronix Ltd.
Inotiv Inc.
Creative Bioarray
MB Research Laboratories

Get Sample Copy Of This Report To Understand The Structure Of The Complete Report@ https://www.persistencemarketresearch.com/samples/33213

Since it can assess the compounds that can induce genetic mutations or chromosomal damages. Additionally, the expansion of facilities and accessibility of funding across the globe is also a considerable growth determinant in the genetic toxicology testing industry.

What are the Prevailing Opportunities in the Genetic Toxicology Testing Market?

COVID-19 and need for reduction of animal employment creating lucrative opportunities

An increasing focus on the reduction of animal employment for evaluation of the genotoxic potential of substances is anticipated to impact the costs and time required for genetic toxicology testing. Such changes in market dynamics are expected to open new opportunities for in-vitro testing and can expect a significant boost in market actions.

The COVID-19 pandemic is considered to have a devastating impact on society, the public healthcare system, and economies across the globe. However, the roles of genetic toxicology testing were neutral in the development of vaccines for COVID-19. Since it wasn't a mandatory requirement by the regulatory bodies from the companies. Toxicity studies were being done to understand the mutation of the virus. Similarly, numerous researchers employed genotoxic to assess the effects of drugs against the COVID-19 virus. For instance, in September 2020, a team of researchers evaluated the impact of Chloroquine (CQ) and Hydroxychloroquine (HCQ) as prophylactic drugs against the virus.

Limitations of Vivo Tests Increasing Preference Towards Vitro Tests?

Safety evaluation of food ingredients spurring adoption of vitro tests

Ethical, scientific, and financial concerns about the use of animals in toxicology testing, have accelerated the interest in the mechanistic in vitro testing approach. For instance, in November 2021, a group of researchers assessed testing strategy with in vitro technique for genotoxicity. Employing in vitro approach resulted in low cost and was less time-consuming.

Similarly, the U.S. FDA released guidelines for the safety evaluation of food ingredients. The recommended genetic toxicity test by the agency includes, and a test employed in bacteria for gene mutations, and an in-vivo test using mammalian hematopoietic cells for chromosomal damage.

While the agency provides alternative options between in vitro mouse lymphoma thymidine kinase+/- gene mutation assay or an in vitro test along with the cytogenetic assessment of chromosomal damage via mammalian cells. The agency stated that there are compounds, wherein in vivo tests do not offer relevant insights. In such cases, in vitro testing is considered to be appropriate.

Hence, the limitations of in vivo tests increase the preference for in vitro tests amongst researchers. Owing to the aforementioned reasons, the in vitro segment is expected to hold 53% market share for genetic toxicology testing market in 2022 and is estimated to have similar momentum during the forecasted period.

To get extensive insights on key trends, request for customization here@ https://www.persistencemarketresearch.com/request-customization/33213

Key Segments Profiled in the Genetic Toxicology Testing Industry Survey

Type

In Vitro
In Vivo

Product

Reagents & Consumables
Assays
Services

Application

Pharmaceutical & Biotechnology
Food Industry
Cosmetics Industry
Other

Region

North America Genetic Toxicology Testing Market
Latin America Genetic Toxicology Testing Market
Europe Genetic Toxicology Testing Market
Asia Pacific Genetic Toxicology Testing Market
Middle East & Africa Genetic Toxicology Testing Market

Buy Full Report Now and Get Up to 20% Discount @ https://www.persistencemarketresearch.com/checkout/33213

Related Reports:

Telemedicine Market
https://www.persistencemarketresearch.com/market-research/telemedicine-market.asp

Robotic Surgery Market
https://www.persistencemarketresearch.com/market-research/robotic-surgery-market.asp

Veterinary Teleradiology Market
https://www.persistencemarketresearch.com/market-research/veterinary-teleradiology-market.asp

Dental Radiology Equipment Market
https://www.persistencemarketresearch.com/market-research/dental-radiology-equipment-market.asp

Contact us:

Persistence Market Research
Address - 305 Broadway, 7th Floor, New York City,
NY 10007 United States
U.S. Ph. - +1-646-568-7751
USA-Canada Toll-free - +1 800-961-0353
Sales - sales@persistencemarketresearch.com

About Us:

Persistence Market Research is a U.S.-based full-service market intelligence firm specializing in syndicated research, custom research, and consulting services. Persistence Market Research boasts market research expertise across the Healthcare, Chemicals and Materials, Technology and Media, Energy and Mining, Food and Beverages, Semiconductor and Electronics, Consumer Goods, and Shipping and Transportation industries. The company draws from its multi-disciplinary capabilities and high-pedigree team of analysts to share data that precisely corresponds to clients' business needs.

This release was published on openPR.